Subcutaneous Corynebacterium parvum in Bladder Cancer
- 1 August 1979
- journal article
- clinical trial
- Published by Wiley in British Journal of Urology
- Vol. 51 (4) , 278-282
- https://doi.org/10.1111/j.1464-410x.1979.tb04709.x
Abstract
Fourteen out of 26 patients with invasive bladder cancer were randomly assigned to receive weekly subcutaneous injections of Corynebacterium parvum (CP) in addition to standard treatment. Peripheral blood T lymphocyte percentage, K cell activity, mitogen responsiveness, and monocyte and polymorph leucotaxis were measured at intervals over a period of 1 to 2 years. The only consistent difference between the CP-treatment patients and the controls was a slightly higher level of K cell activity in the former, who, however, fared rather worse than the controls in terms of survival.Keywords
This publication has 8 references indexed in Scilit:
- EFFECT OF CORTISONE ACETATE ON EFFECTOR CELLS FOR ANTIBODY-MEDIATED CYTOTOXICITY IN MOUSE AND RATTransplantation, 1978
- In Vitro Antitumor Effect of Lymphoid Cells From Corynebacterium parvum-Treated Mice: Effect of Route of C. parvum Administration2JNCI Journal of the National Cancer Institute, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- A raft technique for chemotaxis: A versatile method suitable for clinical studiesJournal of Immunological Methods, 1976
- Brief Communication: Daily Intravenous Infusions of Corynebacterium parvum in Twenty Patients With Disseminated Cancer: A Preliminary Report of Clinical and Biologic FindingsJNCI Journal of the National Cancer Institute, 1975
- Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor ImmunityPublished by Elsevier ,1974
- LYMPHOPENIA AND CHANGE IN DISTRIBUTION OF HUMAN B AND T LYMPHOCYTES IN PERIPHERAL BLOOD INDUCED BY IRRADIATION FOR MAMMARY CARCINOMAThe Lancet, 1972